Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
News provided by
Share this article
Share this article
SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ Singlera Genomics Inc. today announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of investors also include Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade Zone Fund, and initial investors from the Series A round such as Greenpine Capital, Prosperico Ventures, and Proxima Ventures joined with follow-on investment. Singlera will utilize this round of financing mainly to expand the company s early cancer screening product research and development pipeline and focus on promoting product registration and commercialization, as well
December 15, 2020
SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ Singlera Genomics Inc. today announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of investors also include Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade Zone Fund, and initial investors from the Series A round such as Greenpine Capital, Prosperico Ventures, and Proxima Ventures joined with follow-on investment. Singlera will utilize this round of financing mainly to expand the company s early cancer screening product research and development pipeline and focus on promoting product registration and commercialization, as well as expanding prospective studies into pan-cancer early screening.
JinkoSolar Holding (NYSE:JKS) saw its stock soar in early trading on the NYSE this morning. As of 10:45 a.m. EST, Jinko shares remain up a healthy 8.2%. And yet, at least at first glance, the news doesn t look great.
So what
Early this morning, JinkoSolar Holding announced that its CEO, chief marketing officer, chief operating officer, chief human resources officer, and chief technology officer have all resigned effective immediately.
Image source: Getty Images.
That sounds pretty bad, but as Jinko explained, all five of these resignations were conducted only to comply with certain business operations and independence requirements of the Shanghai Stock Exchange Science and Technology Innovation Board (the STAR Market ).
JinkoSolar Holding Appoints Chairman Xiande Li As CEO
WASHINGTON (dpa-AFX) - JinkoSolar Holding Co., Ltd. (JKS) announced Tuesday changes to its senior management team, in order to comply with certain business operations and independence requirements of the Shanghai Stock Exchange Science and Technology Innovation Board, in relation to the proposed listing of its principal operating subsidiary, Jinko Solar Co., Ltd.
Kangping Chen, Gener Miao, Jiun-Hua Allen Guo, Shaoguo Ji and Dr. Hao Jin have resigned as chief executive officer, chief marketing officer, chief operating officer, chief human resources officer and chief technology officer of JinkoSolar, respectively, effective immediately, but will carry out their respective responsibilities at Jiangxi Jinko.
JinkoSolar s key senior management resign from holding company to pre-IPO operating subsidiary pv-tech.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pv-tech.org Daily Mail and Mail on Sunday newspapers.